Novocaine (2025 film)
2025 film directed by Dan Berk and Robert Olsen
Novocaine (known as Mr. No Pain in some regions and Novocaine No Pain in Australia) is a 2025 action comedy film directed by Dan Berk and Robert Olsen and written by Lars Jacobson. It was a co-production of the United States, Canada, and South Africa. The film stars Jack Quaid, Amber Midthunder, Ray Nicholson, Betty Gabriel, Matt Walsh, and Jacob Batalon. Its plot follows Nathan Caine (Quaid), a bank employee with the inability to feel pain who goes out to rescue his co-worker (Midthunder) after she is taken hostage by a group of bank robbers.
Novocaine was released in the United States by Paramount Pictures on March 14, 2025. The film grossed $34.5 million worldwide and received positive reviews from critics.
Plot
Nathan Caine is an introvert with congenital insensitivity to pain with anhidrosis (CIPA) working as an assistant manager at a trust credit union in San Diego. His co-worker Sherry Margrave is interested in him, but Nathan is hesitant due to his condition and inexperience with women. At a bar with Sherry, Nathan encounters a middle-school bully who calls him "Novocaine".
This brief starts where responsible research should: with the source description of “Novocaine (2025 film)” as 2025 film directed by Dan Berk and Robert Olsen. Everything that follows is an evidence route, not borrowed authority.
Why this record matters
The subject matters to the arts & letters register because the source frames it as 2025 film directed by Dan Berk and Robert Olsen. Its deeper value depends on whether names, dates, institutions and citations support that framing.
Attribution, date and provenance are strongest when supported by the original work, a catalogue record and documented transmission. The source revision retrieved here is dated Sep 9, 2026. The linked authority identifier is Q124707042. 4 of 5 selected statements include explicit references; 5 carry qualifiers and 0 use preferred rank. The first chronological checks are 2025.
Rights, attribution and provenance may remain disputed even when a general reference summary presents a stable account. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Separate the work, its editions or performances, and its later reception. Catalogue records, publication histories and object files often preserve different parts of that story.
- Identifying works and editions
- Tracing reception history
- Finding collection records
The original object or edition, catalogue raisonné, performance record, rights file and holding institution.
Three-step research path
- Establish the record: confirm the title “Novocaine (2025 film)”, its source revision and the description used here.
- Expand the search: follow Novocaine (2025 film) primary sources, Novocaine (2025 film) archive and Novocaine research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Novocaine (2025 film)”?
- Which edition, object, performance or recording is being described?
- Where is authorship, date or provenance documented?
Search terms from this dossier
This entry incorporates text from “Novocaine (2025 film)” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.